Pentagon removes WuXi AppTec from Chinese military companies list

The Pentagon has removed Shanghai-headquartered WuXi AppTec from its list of Chinese military companies, complying with a federal court injunction against enforcing the designation while leaving open the option of relisting the company.

Why it matters: The delisting lifts, for now, the contract and funding restrictions that followed WuXi AppTec's June designation, a live test of how far US biotechnology restrictions on Chinese suppliers can go before courts intervene.

Data as of November 9, 2026, Toronto: US Department of Defense removal notice in the Federal Register, as reported by Reuters and Pharma Manufacturing on November 9, 2026; the underlying US District Court injunction was issued August 7, 2026. The Endpoints News article that first surfaced the item is paywalled beyond its lede; this brief is written from the second-route reporting above. Developing item.

The US Department of Defense has removed WuXi AppTec from its Section 1260H list of Chinese military companies, according to a government posting reported by Reuters on Monday. The deputy secretary of defense made the determination in light of a federal court in Washington enjoining the department from enforcing the designation, which WuXi AppTec had challenged as arbitrary, capricious and the product of political pressure.

The removal complies with the US District Court for the District of Columbia’s August 7 order granting WuXi AppTec’s motion for a preliminary injunction, and the department said it was acting without prejudice to relisting the company on additional or supplementary grounds. WuXi AppTec, a Shanghai-headquartered contract research and manufacturing group heavily used by Western drugmakers, was designated in June 2026, when the Pentagon expanded the list to 188 entities.

Pentagon removes WuXi AppTec from Chinese military companies list

Sources